Environmental Disruptors of Reproductive Physiology
Project Number5K02ES011726-02
Former Number1K02ES000384-01A1
Contact PI/Project LeaderARCARO, KATHLEEN FRANCES
Awardee OrganizationUNIVERSITY OF MASSACHUSETTS AMHERST
Description
Abstract Text
OVERALL DESCRIPTION (provided by applicant)
The purpose of this proposal is to provide Dr. Arcaro with release-time from
teaching and administration so that she can devote 100% of her professional
efforts to developing her research career by incorporating modem molecular
genetic techniques into her research program. Dr. Arcaro is a Research
Assistant Professor in the Department of Environmental Health and Toxicology,
School of Public Health, University at Albany. Her newly established
laboratory, is on the East Campus, a center for the University, at Albany's
new initiative to promote research in science and technology. Dr. Arcaro s
immediate research goal is to determine the mechanisms by which mixtures of
polychlorinated biplienyls (PCBs) and polycyclic aromatic hydrocarbons (PAHs)
disrupt estrogenic responses. Her long-term career objectives are to
understand how exposure to toxic environmental chemicals impacts human health,
and contribute knowledge that will ultimately lesson the burden of
environmentally-related diseases. There is widespread concern that exposure
to chemicals in the environment may, be related to the observed increase in
the incidence of breast cancer. PCBs and PAHs are of particular concern due
to their potential to disrupt estrogenic responses. It is difficult to
predict the health effects of exposure to complex mixtures of these chemicals
because individual congeners of PCBs and PAHs can be either estrogenic or
antiestrogenic and act through a variety of mechanisms potentially leading to
additive. Antagonistic or synergistic effects. Furthermore, the microbial
reductive dechlorination of PCBs and the metabolic transformation of both PCBs
and PAHs within the body may substantially alter the activity of these
mixtures. It is hypothesized that reductive dechlorination of PCBs increases
the estrogenic activity of the resulting mixture, and that metabolism of PCBs
and PAHs further alters the estrogenic and antiestrogenic activity of these
mixtures. Thus, the objective of the research project is to determine how
mixtures of PCBs and PAHs may interact and modulate estrogenic activity, in
humans. Dr. Arcaro's career development plan includes learning to use modern
molecular genetic techniques to determine the ways in which exposure to
environmental toxicants affects human health. Specifically, she will: 1) test
the will hypothesis that the estrogen receptor plays a role in the
carcinogenicity of PAHs, and 2) examine the modulation of gene expression
(using microarray technology) in breast cells exposed to complex mixtures of
environmental toxicants.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
153926712
UEI
VGJHK59NMPK9
Project Start Date
15-September-2001
Project End Date
31-August-2006
Budget Start Date
01-September-2002
Budget End Date
31-August-2003
Project Funding Information for 2002
Total Funding
$92,761
Direct Costs
$85,890
Indirect Costs
$6,871
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Environmental Health Sciences
$92,761
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K02ES011726-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K02ES011726-02
Patents
No Patents information available for 5K02ES011726-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K02ES011726-02
Clinical Studies
No Clinical Studies information available for 5K02ES011726-02
News and More
Related News Releases
No news release information available for 5K02ES011726-02
History
No Historical information available for 5K02ES011726-02
Similar Projects
No Similar Projects information available for 5K02ES011726-02